Back to search

Boston University

Risk factors in the occurrence and diagnosis of myeloid neoplasms

Abstract

dc:description.abstract

Risk factors for the development and diagnosis of myeloid neoplasms (MN) are not well understood. We conducted three studies using the United Kingdom based General Practice Research Database, a large database with information on medical conditions and drug prescriptions. Benzodiazepines (BZDs) are drugs that interact with a receptor in hematopoietic cells involved in apoptosis, but their effect on MN is unknown. In the first study, we estimated the relative risk of MN in patients taking BZDs. There was a slightly increased risk for myelodysplastic syndromes (MDS) (adjusted odds ratio [OR] 1.6, 95% confidence interval [CI] 1.1, 2.2) and a smaller increased risk for acute myeloid leukemia (AML) and primary myelofibrosis (PMF). However, there was no dose-response relationship, making a causal effect unlikely. Unlike BZDs, certain immunosuppressant drugs are known to increase the risk of MN, although it is unclear whether autoimmune disorders that these drugs are used for also increase the risk of MN. In the second study, we estimated the relative risk of MN in patients with autoimmune disorders, both with and without treatment, as compared with patients without autoimmune disorders. There was a slightly increased risk of MDS in patients with any autoimmune disorder (OR 1.5, 95% CI 1.1, 2.0). Autoimmune disorders also conferred a small potential increase in risk of essential thrombocythemia (ET), PMF, and other myeloproliferative neoplasms. However, it is difficult to determine whether autoimmune disorders increased the risk of MN, or whether the small elevation in the effect estimate was an artifact of misdiagnosis resulting from early MN symptoms that are similar to those of autoimmune disorders. In the third study, we explored the role of surveillance bias in MN diagnosis. There was an increased risk of MDS in patients with a history of frequent blood tests (OR 2.4, 95% CI 1.3, 4.5) that was not present for AML (OR 1.1, 95% CI 0.5, 2.3) or chronic myeloid leukemia (OR 0.7, 95% CI 0.2, 3.1). The increased risk for MDS may be a result of the long-term physician monitoring prior to a diagnosis, or surveillance bias leading to a diagnosis of otherwise indolent cases.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Epidemiology
Grantor dc:publisher
Boston University
Year dc:date.issued
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wilson, Amanda Beth

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Dc Identifier Other
(ALMA)contemp

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Wilson, Amanda Beth. Risk factors in the occurrence and diagnosis of myeloid neoplasms. doctoral thesis, Boston University, 2012. https://hdl.handle.net/2144/12674